CMS 129 - Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients

Overview

CMS129v9 (2020)

CMS129v10 (2021)

CMS129v11 (2022)

Identifiers

CMS eCQM ID NQF eCQM ID NQF MIPS Quality ID
CMS129v11 0389e 0389 102

*MIE only supports data collection and reporting using eCQM specifications

Definitions

Description Percentage of patients, regardless of age, with a diagnosis of prostate cancer at low (or very low) risk of recurrence receiving interstitial prostate brachytherapy, OR external beam radiotherapy to the prostate, OR radical prostatectomy who did not have a bone scan performed at any time since diagnosis of prostate cancer
Initial Patient Population All patients, regardless of age, with a diagnosis of prostate cancer
Denominator Equals Initial Population at low (or very low) risk of recurrence receiving interstitial prostate brachytherapy, OR external beam radiotherapy to the prostate, OR radical prostatectomy
Denominator Exclusions
Numerator Patients who did not have a bone scan performed at any time since diagnosis of prostate cancer
Numerator Exclusions
Denominator Exceptions Documentation of reason(s) for performing a bone scan (including documented pain, salvage therapy, other medical reasons, or bone scan ordered by someone other than reporting clinician)

Additional Information

Measure Type Process measure
Measure Scoring Proportion measure
Granularity Patient
Improvement Notation Higher score indicates better quality
Domain Efficiency and Cost Reduction

Clinical Instructions

New UI Visit Encounter (valid RC202109+)

Original Visit Encounter

Evidence

Initial Patient Population

Name Value Set
Diagnosis: Prostate Cancer 2.16.840.1.113883.3.526.3.319
Laboratory Test, Performed: Gleason score in Specimen Qualitative LOINC Code 35266-6
Laboratory Test, Performed: Prostate Specific Antigen Test 2.16.840.1.113883.3.526.3.401
Procedure, Performed: Cancer staging (tumor staging) SNOMEDCT Code 258232002

Denominator Exclusions

Name Value Set
Diagnosis: Pain Related to Prostate Cancer 2.16.840.1.113883.3.526.3.451
Procedure, Performed: Prostate Cancer Treatment 2.16.840.1.113883.3.526.3.398

Numerator

Name Value Set
Diagnostic Study, Performed: Bone Scan 2.16.840.1.113883.3.526.3.320

Source(s)

eCQI CMS129

Was this page helpful?

Let us know how we can improve this documentation.

Published: April 22, 2022